Addiction Psychiatry Annual Review: 2024 Highest Impact Publications-Addiction Psychiatry Annual Review: 2024 Highest Impact Publications

Video Transcription

Video Summary

The symposium covered a wide range of topics in addiction medicine, emphasizing the importance of current research and its application in clinical settings. Dr. Carla Marienfeld, along with co-presenters Dr. Joshua Lee and Dr. Brian Hurley, led the symposium, which highlighted significant publications in addiction medicine. Key topics included the examination of high-impact articles that garnered media attention and their clinical implications, spanning issues like overdose, cannabis, GLP-1 agonists, electronic nicotine delivery systems, and stimulants.<br /><br />The symposium began by outlining the methodology of selecting top publications, utilizing an altmetric score to determine media influence and relevance. The studies presented were diverse, covering subjects such as the impact of drug decriminalization on overdose rates, cannabis use during pregnancy, and innovative treatment approaches for stimulant use disorder. The symposium also discussed the implications of increased stimulant prescriptions during the pandemic and the potential benefits and risks associated with GLP-1 agonists.<br /><br />There was a panel discussion with experts, including Dr. Larissa Mooney and Dr. Daryl Shorter, who provided insights on the clinical application of the research findings. They emphasized the importance of interdisciplinary collaboration, the nuances of prescribing practices, and the need for increased awareness of addiction-related issues among healthcare providers.<br /><br />The session concluded with an acknowledgment of the complex nature of addiction treatment, the necessity for continued research, and the promise of emerging therapeutic approaches. The discussions highlighted both the challenges and opportunities within the field, encouraging a more evidence-based and patient-centered approach to addiction medicine.

Keywords

opioid crisis

fentanyl

xylazine

drug overdose

naloxone

telehealth

racial disparities

American Indian

Alaskan Native

Black populations

Trank

dexmedetomidine

carfentanil

harm reduction

naloxone distribution

addiction medicine

clinical research

overdose

cannabis

GLP-1 agonists

stimulants

drug decriminalization

treatment approaches

interdisciplinary collaboration

prescribing practices

addiction treatment

emerging therapeutics

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events